GlassScriptPhysician profile
Michelle Frey
NPI 1538509237
$3,062.55
in general payments reported to CMS, 2019-2025
19 companies · $1,656 in 2025
The $1,656 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2022: $331 · 2023: $399 · 2024: $386 · 2025: $1,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,376 · Travel and Lodging: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,375.94 |
| Travel and Lodging | $1,065.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,432.79 | 2023-2025 | Minimed 780g |
| Amgen INC. | $577.44 | 2021-2025 | Evenity, Repatha, Prolia |
| Lilly USA, LLC | $169.22 | 2021-2024 | Jardiance, Lyumjev, Zepbound |
| Novo Nordisk INC | $120.17 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Beta Bionics, INC. | $118.16 | 2024 | Ilet Bionic Pancreas |
| Dexcom, INC. | $113.79 | 2021-2024 | Dexcom G6 Transmitter |
| Horizon Therapeutics Plc | $97.33 | 2023 | Tepezza |
| Ascendis Pharma Endocrinology INC | $84.42 | 2025 | Yorvipath |
| Abbott Laboratories | $68.29 | 2022-2024 | Freestyle Libre 3 |
| Insulet Corporation | $63.53 | 2021-2024 | Omnipod |
| Abbvie INC. | $47.08 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $37.36 | 2022-2023 | |
| Xeris Pharmaceuticals, INC. | $24.58 | 2022 | |
| Antares Pharma, INC. | $22.72 | 2022 | |
| Sequel Med Tech, LLC | $18.02 | 2025 | Twiist |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $17.82 | 2021 | |
| Mannkind Corporation | $17.44 | 2023 | Afrezza |
| Chiesi USA, INC. | $17.44 | 2025 | Mycapssa |
| Amneal Pharmaceuticals LLC | $14.95 | 2023 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.